290 related articles for article (PubMed ID: 18551203)
1. Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.
Vahid B; Marik PE
Can Respir J; 2008; 15(4):211-6. PubMed ID: 18551203
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced respiratory disease in patients with hematological diseases.
Camus P; Costabel U
Semin Respir Crit Care Med; 2005 Oct; 26(5):458-81. PubMed ID: 16267698
[TBL] [Abstract][Full Text] [Related]
3. Assessing the effects of treatments for hematological malignancies on prepubertal growth.
Pearce MS
Pediatr Hematol Oncol; 2000 Sep; 17(6):441-3. PubMed ID: 10989463
[No Abstract] [Full Text] [Related]
4. [Lung injury].
Saito Y; Gemma A
Nihon Rinsho; 2012 Aug; 70 Suppl 6():159-65. PubMed ID: 23156502
[No Abstract] [Full Text] [Related]
5. [Evaluation of drug-induced lung disease--guideline for the treatment].
Nihon Kokyuki Gakkai Zasshi; 2006 Apr; Suppl():1-69. PubMed ID: 16703680
[No Abstract] [Full Text] [Related]
6. Pulmonary toxicity and cancer treatment.
Fennell DA; Rudd RM
Hosp Med; 2004 Aug; 65(8):462-5. PubMed ID: 15330346
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary side effects of interferon-alpha therapy in patients with hematological malignancies.
Anderson P; Höglund M; Rödjer S
Am J Hematol; 2003 May; 73(1):54-8. PubMed ID: 12701122
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary disease in patients with hematologic malignancies.
Poletti V; Trisolini R; Tura S
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Mar; 19(1):29-45. PubMed ID: 12002382
[TBL] [Abstract][Full Text] [Related]
9. Management of hematological malignancies during pregnancy.
Rizack T; Mega A; Legare R; Castillo J
Am J Hematol; 2009 Dec; 84(12):830-41. PubMed ID: 19844988
[TBL] [Abstract][Full Text] [Related]
10. [Protocol for the Prevention of Infections Related to the Treatment of Hematological Malignancies].
Silva-Pinto A; Rocha-Pereira N; Andrade J; Sarmento A; Santos L
Acta Med Port; 2018 Jun; 31(6):347-361. PubMed ID: 30020882
[TBL] [Abstract][Full Text] [Related]
11. An update on the management of hematologic malignancies in pregnancy.
Lavi N; Horowitz NA; Brenner B
Womens Health (Lond); 2014 May; 10(3):255-66. PubMed ID: 24956292
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary complications in chemotherapy].
Becker A; Frauenfelder T
Radiologe; 2014 Oct; 54(10):1023-38. PubMed ID: 25316105
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications of cancer therapy.
Wesselius LJ
Compr Ther; 1999 May; 25(5):272-7. PubMed ID: 10390656
[TBL] [Abstract][Full Text] [Related]
14. Management of hematological malignancies in patients affected by renal failure.
Niscola P; Vischini G; Tendas A; Scaramucci L; Giovannini M; Bondanini F; Romani C; Brunetti GA; Cartoni C; Cupelli L; Ferrannini M; Perrotti A; Del Poeta G; Palumbo R; de Fabritiis P
Expert Rev Anticancer Ther; 2011 Mar; 11(3):415-32. PubMed ID: 21417855
[TBL] [Abstract][Full Text] [Related]
15. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
16. [Terminal care. II. Easing of symptoms of cancer patients. 5. Management of adverse effects of antineoplastic agents].
Kurihara M; Matsukawa M; Yamamoto W; Sato A; Cho T; Akazawa S
Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2032-8. PubMed ID: 9036169
[No Abstract] [Full Text] [Related]
17. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
Min HK; Lee B; Kwok SK; Ju JH; Kim WU; Park YM; Park SH
Korean J Intern Med; 2015 Jul; 30(4):521-30. PubMed ID: 26161019
[TBL] [Abstract][Full Text] [Related]
18. An open-label phase I dose-finding study of APR-246 in hematological malignancies.
Deneberg S; Cherif H; Lazarevic V; Andersson PO; von Euler M; Juliusson G; Lehmann S
Blood Cancer J; 2016 Jul; 6(7):e447. PubMed ID: 27421096
[No Abstract] [Full Text] [Related]
19. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
[No Abstract] [Full Text] [Related]
20. Pulmonary toxicity of antineoplastic therapy.
Kreisman H; Wolkove N
Semin Oncol; 1992 Oct; 19(5):508-20. PubMed ID: 1411649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
